跳至主要内容
临床试验/NCT02861339
NCT02861339已完成不适用

Prevalence of Keratoconus in Inflammatory Bowel Diseases

Central Hospital, Nancy, France0 个研究点目标入组 201 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
201
主要终点
Absence or presence of keratoconus in IBD patients

研究概览

简要总结

A retrospective study has shown the association between the inflammatory bowel diseases (IBD) and the presence of a keratoconus. This new study will measure the prevalence of keratoconus and follow its activity in patients affected by IBD and followed up in hepatology-gastroenterology department at Nancy Hospital. The prevalence of keratoconus will be compared to known data of literature about general population.

The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD.

Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Informed consent
  • •Affiliation to social security plan
  • •Diagnosis of IBD since more than 3 years, under treatment or not

排除标准

  • •Protected person
  • •Pregnant or breastfeeding women
  • •Person in life-and-death emergency
  • •Person deprived of liberty
  • •Refusal to remove contact lenses, where necessary

研究组 & 干预措施

Keratoconus and IBD

Experimental

Opthalmologic measure with DM OPD scan III (Nidek)

干预措施: Opthalmologic measure with DM OPD scan III (Nidek) (Device)

结局指标

主要结局

Absence or presence of keratoconus in IBD patients

时间窗: day 0

Data from OPD scan III corneal analyzer according to Rabinowitz and Klyce Maeda criteria. The presence of a keratoconus in at least one eye is considered positive.

次要结局

  • IBD clinical features using the Montreal classification for IBD(day 0)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

相似试验